Big difference between a 'cannabis/weed stock' and a 'pharmaceutical/medical cannabis stock'. And from what I can see on the ASX MDC is leading the medical cannabis space with well advanced clinical trials heading into Phase 3, with increasing sales via SAS and doctors confidently prescribing. MDC was one of the first listed stocks on ASX with its sites set on this space (June 2015). Not just a late comer trying to capitalise on the hype. 3 cannabis medicines Hemp CBD, Cannabis CBD and a 1:1 THC:CBD. And then there is the nutraceutical side of the business with UK, US and Asia distribution deals only just begun. Surely the penny will drop some day.
Add to My Watchlist
What is My Watchlist?